UC incidence and prevalence have rapidly increased in Asia over the past four decades, particularly in Australia and Japan
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more